Contineum Therapeutics, Inc. Class A Balance Sheet
Contineum Therapeutics, Inc. Class A's total assets for Q3 2025 were $190.85M, an increase of 4.35% from the previous quarter. CTNM total liabilities were $10.38M for the fiscal quarter, a -9.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.